Attached files
file | filename |
---|---|
EX-23.1 - EX-23.1 - FINJAN HOLDINGS, INC. | b81669exv23w1.htm |
EX-99.1 - EX-99.1 - FINJAN HOLDINGS, INC. | b81669exv99w1.htm |
EX-99.2 - EX-99.2 - FINJAN HOLDINGS, INC. | b81669exv99w2.htm |
8-K/A - 8-K/A AMENDMENT NO. 2 - FINJAN HOLDINGS, INC. | b81669e8vkza.htm |
Exhibit 99.3
INDEX
TERRASPHERE SYSTEMS LLC.
CONVERTED ORGANICS INC.
UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS |
||||
Introduction |
||||
Unaudited Pro Forma Consolidated Balance Sheet as of March 31, 2010 |
||||
Unaudited Pro Forma Consolidated Statements of Operations and Comprehensive
Income (Loss) for the three month period ended March 31, 2010 |
||||
Unaudited Pro Forma Consolidated Statements of Operations and Comprehensive
Income (Loss) for the year ended December 31, 2009 |
||||
Notes to Unaudited Pro Forma Consolidated Financial Statements |
UNAUDITED
PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
Introduction
On July 6, 2010, Converted Organics Inc. (the
Company) and its wholly-owned subsidiary TerraSphere
Inc. entered into a membership interest purchase agreement
(Agreement) with TerraSphere Systems LLC to acquire
100% of the membership interests in TerraSphere Systems LLC
(TerraSphere) subject to, among other items, the
Companys shareholder approval. This acquisition enables
the Company to license TerraSpheres patented Growth
System, which is a system of modules and processes for growing
plants in a controlled environment. The system uses and controls
precise combinations of light, water, nutrition, gravity,
centrifugal forces, and gasses to produce growing conditions
that can be controlled and manipulated to result in desired
plant growth and maximum crop production.
Terms
The Agreement allows for an election by TerraSphere members to
accept 1) a purchase price of $21,000,000 of Company common
stock upon closing of the transaction (with a 6 month
holding period) (Option One) or 2) a purchase
price of $12,000,000 of Company common stock upon closing of the
transaction with an option to earn an additional $16,000,000 in
contingent consideration based upon TerraSphere achieving
certain milestones and agreeing to an 18 month holding
period on stock distributed to them (Option Two).
Based on 31% of TerraSphere members electing Option One
and 69% electing Option Two, the maximum total purchase price is
$25,830,000 payable in the Companys common stock valued at
$0.756 per share. Per the Agreement, TerraSphere members who
elected Option One will receive $6,510,000 upon closing and
members electing Option Two will receive $8,280,000 upon closing
and up to an additional $11,040,000 based on achieving the
defined milestones (contingent consideration).
Milestone One Payment: $3,450,000 of Company
common stock, if, and only if, between the date of the Agreement
and the 90th day following the closing date or the
180th day following the date of the Agreement, the
following occurs (such shares to be payable within ten
(10) business days of achievement of the following or the
closing date, whichever is later): For a period of five
(5) consecutive trading days, the Companys market
capitalization exceeds the sum of: (1) the Companys
initial market capitalization on the date of execution of the
Agreement, plus (2) the closing price per share, or $0.756,
multiplied by the number of shares of Company common stock to be
issued at closing pursuant to the Agreement, and, if such
calculation is being made prior to the closing date, including
this Milestone One. If between the date of the Agreement and the
90th day following the closing date or the 180th day
following the date of the Agreement, the Company completes an
equity financing, the cash received from the equity financing
during such period shall be added to the market capitalization.
If between the closing date and December 31, 2011, the
Buyer sells equity of either the Company or any of the
Companys subsidiaries, any cash received from such equity
sales during such period shall be added to the market
capitalization;
Milestone Two Payment: $1,380,000 of Company
common stock, if, and only if, $2,000,000 of TerraSpheres
accounts receivable as of the date of the Agreement are received
prior to February 28, 2011;
Milestone Three Payment: $3,450,000 of Company
common stock, if, and only if, the Company generates gross
margin of $6,000,000 (gross margin target) from its operations
during the period commencing as of the date of the Agreement and
ending on December 31, 2011; provided that, if the Company
generates gross margin of at least $4,200,000 (gross margin
threshold) from its operations during such period, the Sellers
shall be entitled to a pro rata portion of the Company
common stock; and
Milestone Four Payment: $2,760,000 of Company
common stock, if, and only if, the Company generates gross
margin of $4,000,000 from its operations during any six-month
period commencing on the Agreement date and ending on
December 31, 2012; provided that, if the Company achieves
the Milestone Three gross margin threshold, but does not achieve
the Milestone Three gross margin target, 83.3% of the difference
between the Milestone Three gross margin target and the actual
gross margins achieved pursuant to the Agreement (the
Milestone Three Deficiency) may be added by the
Sellers to the Milestone Four Payment and the Milestone Four
gross margin target. Notwithstanding anything to the contrary
herein, the total
amounts payable pursuant to the Milestone Three Payment and
Milestone Four Payment shall be no more than $6,210,000 of
Company common stock.
The Company used the following assumptions to calculate fair
value of the contingent consideration:
Milestone One: The acquisition of TerraSphere
will diversify the Companys base while still sustaining
business practices that protect and value the environment,
current customers, colleagues, and shareholders. The likelihood
of meeting this milestone is largely dependent on the state of
the U.S. economy and future market conditions, both of
which are uncertain and unpredictable. If the U.S. economy
becomes stagnant or the market conditions are not favorable for
investors, the Company may not achieve this milestone. Based on
the uncertainty of the U.S. economy and the unpredictability of
the market over the next 6-12 months, the Company has
estimated that the likelihood of achieving this milestone is 75%
and, as such, has determined that the fair value of this
contingent payment is $2,588,000.
Milestone Two: The Company has reviewed the
customers credit worthiness and ability to make the
required installment payments. Based on this information, the
Company has estimated that the likelihood of achieving this
milestone is 95% and, as such, has determined that the fair
value of this contingent payment is $1,311,000.
Milestones Three and Four: The Company has
evaluated milestones three and four together as they can be
achieved over the same milestone period. The Company has
reviewed TerraSpheres operating estimates and historical
data and believes these milestones are achievable.
TerraSpheres plans are based on the U.S. economy
continuing to grow at a steady rate, investors investing in new
technology and market acceptance of the Growth System
technology. If the U.S. economy becomes stagnant or the
market conditions are not favorable or the technology is not
well received during the milestone periods, the Company may not
achieve the milestones. Based on the uncertainty of the U.S.
economy and the unpredictability of the market over the next
36 months, the Company has estimated that the likelihood of
achieving milestones three and four is 50% and as such, has
determined that the fair value of these contingent payments is
$3,105,000.
The estimated purchase price at fair value is as follows:
Election of Option One
|
$ | 6,510,000 | ||
Election of Option Two
|
8,280,000 | |||
Milestone one payment
|
2,588,000 | |||
Milestone two payment
|
1,311,000 | |||
Milestones three and four payments
|
3,105,000 | |||
$ | 21,794,000 | |||
The following unaudited pro forma consolidated financial
information gives effect to the Company acquiring 100% of the
membership interests in TerraSphere Systems, LLC and should be
read in conjunction with the Companys
Form 8-K
dated July 6, 2010 and filed on July 7, 2010, the
historical financial statements and the related notes of
Converted Organics Inc., which are included in the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2009, the quarterly
financial statements and the related notes of Converted
Organics, Inc., which are included in the Companys
Form 8-K
as of March 31, 2010, the TerraSphere Systems, LLC
financial statements which are included in this proxy statement.
The unaudited pro forma consolidated balance sheet as of
March 31, 2010 gives effect to the acquisition of
TerraSphere Systems, LLC transaction as if it had occurred on
March 31, 2010, and the unaudited pro forma consolidated
statements of operations and comprehensive income (loss) for the
year ended December 31, 2009 and for the three month period
ended March 31, 2010 give effect to the acquisition as if
it had occurred on January 1, 2009.
The unaudited pro forma consolidated financial statements
include all material pro forma adjustments necessary for their
preparation, as required by Article 11 of
Regulation S-X
and, accordingly, do not assume any benefits from cost savings
or synergies of operations.
The pro forma adjustments are based upon available information
and certain assumptions that the Company believes are
reasonable. The unaudited pro forma consolidated financial
statements do not purport to represent what the Companys
financial condition or results of operations would actually have
been had these transactions in fact occurred as of the dates
indicated above or to project the Companys results of
operations for the period indicated or for any other period.
Changes in the fair value of contingent consideration that the
Company recognizes after the acquisition date may be the result
of additional information about facts and circumstances that
existed at the acquisition date that the Company obtained after
that date. Such changes are considered to be measurement period
adjustments and would adjust the purchase price for changes
within one year from the acquisition date. Contingent
consideration classified as an asset or a liability that exceed
a year from the acquisition date is remeasured at fair value and
recognized in earnings.
CONVERTED
ORGANICS INC.
AS OF
MARCH 31, 2010
Historical |
Pro |
Pro |
||||||||||||||
Converted Organics |
Forma |
Forma |
||||||||||||||
Inc. and Subsidiaries | Adjustments | Reference | Consolidated | |||||||||||||
ASSETS
|
||||||||||||||||
CURRENT ASSETS
|
||||||||||||||||
Cash and cash equivalents
|
$ | 4,113,359 | $ | 106,830 | (1 | ) | $ | 4,220,189 | ||||||||
Restricted cash
|
233,316 | | 233,316 | |||||||||||||
Accounts receivable, net
|
495,450 | 950,000 | (1 | ) | 1,445,450 | |||||||||||
Inventories
|
371,301 | | 371,301 | |||||||||||||
Prepaid rent
|
641,781 | | 641,781 | |||||||||||||
Other prepaid expenses
|
624,319 | 106,521 | (1 | ) | 730,840 | |||||||||||
Total current assets
|
6,479,526 | 1,163,351 | 7,642,877 | |||||||||||||
Deposits
|
800,419 | 5,886 | (1 | ) | 806,305 | |||||||||||
Restricted cash
|
29,769 | | 29,769 | |||||||||||||
Other assets
|
166,667 | | 166,667 | |||||||||||||
Property and equipment, net
|
18,382,828 | 158,819 | (1 | ) | 18,541,647 | |||||||||||
Construction-in-progress
|
328,637 | 81,017 | (1 | ) | 409,654 | |||||||||||
Capitalized bond costs, net
|
802,424 | | 802,424 | |||||||||||||
Intangible assets, net
|
1,923,617 | 10,000,000 | (1 | ) | 11,923,617 | |||||||||||
Goodwill
|
| 12,370,000 | (1 | ) | 12,370,000 | |||||||||||
Total assets
|
$ | 28,913,887 | $ | 23,779,073 | $ | 52,692,960 | ||||||||||
LIABILITIES AND OWNERS EQUITY (DEFICIT) | ||||||||||||||||
CURRENT LIABILITIES
|
||||||||||||||||
Term notes payable current
|
$ | 1,812,764 | $ | 184,351 | (1 | ) | $ | 1,997,115 | ||||||||
Accounts payable
|
1,150,770 | 1,353,304 | (1 | ) | 2,504,074 | |||||||||||
Accrued compensation, officers, directors and consultants
|
455,218 | | 455,218 | |||||||||||||
Accrued legal and other expenses
|
708,095 | 12,834 | (1 | ) | 720,929 | |||||||||||
Accrued interest
|
249,191 | | 249,191 | |||||||||||||
Deferred revenue
|
| 434,584 | (1 | ) | 434,584 | |||||||||||
Convertible notes payable, net of unamortized discount
|
286,450 | | 286,450 | |||||||||||||
Capital lease obligations current
|
12,069 | | 12,069 | |||||||||||||
Total current liabilities
|
4,674,557 | 1,985,073 | 6,659,630 | |||||||||||||
Capital lease obligation, net of current portion
|
25,654 | | 25,654 | |||||||||||||
Term notes payable, net of current portion
|
509,833 | | 509,833 | |||||||||||||
Derivative liabilities
|
2,261,897 | | 2,261,897 | |||||||||||||
Bonds payable
|
17,500,000 | | 17,500,000 | |||||||||||||
Total liabilities
|
24,971,941 | 1,985,073 | 26,957,014 | |||||||||||||
COMMITMENTS AND CONTINGENCIES
|
| | | |||||||||||||
OWNERS EQUITY (DEFICIT)
|
||||||||||||||||
Preferred stock, $.0001 par value, authorized
|
||||||||||||||||
10,000,000 shares; no shares issued and outstanding
|
| | | |||||||||||||
Common stock, $.0001 par value, authorized
75,000,000 shares
|
3,802 | 1,852 | (1 | ) | 5,654 | |||||||||||
Additional paid-in capital
|
60,209,902 | 21,792,148 | (1 | ) | 82,002,050 | |||||||||||
Accumulated deficit
|
(56,271,758 | ) | | (56,271,758 | ) | |||||||||||
Total owners equity
|
3,941,946 | 21,794,000 | 25,735,946 | |||||||||||||
Total liabilities and owners equity
|
$ | 28,913,887 | $ | 23,779,073 | $ | 52,692,960 | ||||||||||
The accompanying notes are an integral part of these unaudited
pro forma consolidated financial statements.
CONVERTED
ORGANICS INC.
UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTH PERIOD ENDED MARCH 31, 2010
UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTH PERIOD ENDED MARCH 31, 2010
Historical | ||||||||||||||||
Converted Organics |
Pro Forma |
Pro Forma |
||||||||||||||
Inc. and Subsidiaries | Adjustments | Reference | Consolidated | |||||||||||||
Revenues
|
$ | 859,826 | $ | 1,684,183 | (2) | $ | 2,544,009 | |||||||||
Cost of good sold
|
1,966,101 | 703,301 | (2) | 2,669,402 | ||||||||||||
Gross loss
|
(1,106,275 | ) | 980,882 | (125,393 | ) | |||||||||||
Operating expenses
|
||||||||||||||||
General and administrative expenses
|
4,089,501 | 436,998 | (2) | 4,526,499 | ||||||||||||
Research and development
|
64,059 | | (2) | 64,059 | ||||||||||||
Depreciation expense
|
2,819 | | 2,819 | |||||||||||||
Amortization of capitalized costs
|
75,371 | 177,484 | (2),(3) | 252,855 | ||||||||||||
Amortization of license
|
8,548 | | 8,548 | |||||||||||||
Loss from operations
|
(5,346,573 | ) | 366,400 | (4,980,173 | ) | |||||||||||
Other income/(expenses)
|
||||||||||||||||
Interest income
|
281 | | 281 | |||||||||||||
Derivative gain/(loss)
|
(635,155 | ) | | (635,155 | ) | |||||||||||
Other income
|
| 17,190 | (2) | 17,190 | ||||||||||||
Interest expense
|
(398,246 | ) | (3,905 | ) | (2) | (402,151 | ) | |||||||||
(1,033,120 | ) | 13,285 | (1,019,835 | ) | ||||||||||||
Loss before provision for income taxes
|
(6,379,693 | ) | 379,685 | (6,000,008 | ) | |||||||||||
Provision for income taxes
|
| | | |||||||||||||
Net loss
|
(6,379,693 | ) | 379,685 | (6,000,008 | ) | |||||||||||
Net income (loss) attributable to noncontrolling interest
|
| (117,507 | ) | (2) | (117,507 | ) | ||||||||||
Net income (loss) attributable to Converted Organics Inc. before
other comprehensive income (loss)
|
(6,379,693 | ) | 497,192 | (5,882,501 | ) | |||||||||||
Other comprehensive income (loss):
|
||||||||||||||||
Foreign currency translation adjustment
|
| (41,766 | ) | (2) | (41,766 | ) | ||||||||||
Comprehensive income (loss)
|
(6,379,693 | ) | 455,426 | (5,924,267 | ) | |||||||||||
Comprehensive income (loss) attributable to noncontrolling
interest
|
| (6,264 | ) | (2) | (6,264 | ) | ||||||||||
Comprehensive income (loss) attributable to Converted Organics
Inc.
|
$ | (6,379,693 | ) | $ | 461,690 | $ | (5,918,003 | ) | ||||||||
Net loss per share, basic and diluted
|
$ | (0.17 | ) | (4) | $ | (0.10 | ) | |||||||||
Weighted average common shares outstanding
|
37,864,169 | (4) | 56,389,068 | |||||||||||||
The accompanying notes are an integral part of these unaudited
pro forma consolidated financial statements.
CONVERTED
ORGANICS INC.
UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME (LOSS)
FOR THE YEAR ENDED DECEMBER 31, 2009
UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME (LOSS)
FOR THE YEAR ENDED DECEMBER 31, 2009
Historical | ||||||||||||||||
Converted Organics |
Pro Forma |
Pro Forma |
||||||||||||||
Inc. and Subsidiaries | Adjustments | Reference | Consolidated | |||||||||||||
Revenues
|
$ | 2,633,782 | $ | 36,732 | (2) | $ | 2,670,514 | |||||||||
Cost of good sold
|
6,914,857 | | 6,914,857 | |||||||||||||
Gross loss
|
(4,281,075 | ) | 36,732 | (4,244,343 | ) | |||||||||||
Operating expenses
|
||||||||||||||||
General and administrative expenses
|
10,049,830 | 1,291,586 | (2) | 11,341,416 | ||||||||||||
Research and development
|
637,142 | 613 | (2) | 637,755 | ||||||||||||
Depreciation expense
|
723,846 | | 723,846 | |||||||||||||
Amortization of capitalized costs
|
357,718 | 673,050 | (2),(3) | 1,030,768 | ||||||||||||
Amortization of license
|
16,500 | | 16,500 | |||||||||||||
Loss from operations
|
(16,066,111 | ) | (1,928,517 | ) | (17,994,628 | ) | ||||||||||
Other income/(expenses)
|
||||||||||||||||
Interest income
|
24,097 | | 24,097 | |||||||||||||
Loss on impairment of long-term assets
|
(3,928,129 | ) | | (3,928,129 | ) | |||||||||||
Derivative gain/(loss)
|
5,766,035 | | 5,766,035 | |||||||||||||
Other income
|
68,995 | 55,114 | (2) | 124,109 | ||||||||||||
Interest expense
|
(6,970,675 | ) | (9,218 | ) | (2) | (6,979,893 | ) | |||||||||
(5,039,677 | ) | 45,896 | (4,993,781 | ) | ||||||||||||
Loss before provision for income taxes
|
(21,105,788 | ) | (1,882,621 | ) | (22,988,409 | ) | ||||||||||
Provision for income taxes
|
| | | |||||||||||||
Net loss
|
(21,105,788 | ) | (1,882,621 | ) | (22,988,409 | ) | ||||||||||
Net income (loss) attributable to noncontrolling interest
|
| 74,934 | (2) | 74,934 | ||||||||||||
Net income (loss) attributable to Converted Organics Inc. before
other comprehensive income (loss)
|
(21,105,788 | ) | (1,957,555 | ) | (23,063,343 | ) | ||||||||||
Other comprehensive income (loss):
|
||||||||||||||||
Foreign currency translation adjustment
|
| (57,491 | ) | (2) | (57,491 | ) | ||||||||||
Comprehensive income (loss)
|
(21,105,788 | ) | (2,015,046 | ) | (23,120,834 | ) | ||||||||||
Comprehensive income (loss) attributable to noncontrolling
interest
|
| (8,623 | ) | (2) | (8,623 | ) | ||||||||||
Comprehensive income (loss) attributable to Converted Organics
Inc.
|
$ | (21,105,788 | ) | $ | (2,006,423 | ) | $ | (23,112,211 | ) | |||||||
Net loss per share, basic and diluted
|
$ | (1.08 | ) | (4) | $ | (0.61 | ) | |||||||||
Weighted average common shares outstanding
|
19,569,853 | (4) | 38,114,781 | |||||||||||||
The accompanying notes are an integral part of these unaudited
pro forma consolidated financial statements.
CONVERTED
ORGANICS INC.
The following numbered notes are referenced on the Unaudited
Pro Forma Consolidated Balance Sheet and Statements of
Operations and Comprehensive Income (Loss).
(1) | The Company purchased 100% of the membership interests in TerraSphere Systems, LLC, for consideration and contingent consideration with an estimated fair value of $21,794,000 all consideration is to be paid in the Companys common stock. |
The estimated purchase price has been allocated to the assets
and liabilities on a preliminary basis using estimated fair
value information currently available. The allocation of the
purchase price to the assets and liabilities will be finalized
within a year as the Company obtains more information regarding
asset valuations, liabilities assumed, contingent consideration
and revisions of preliminary estimates of fair value made as the
date of purchase. The preliminary purchase price allocation is
as follows:
Cash and cash equivalents
|
$ | 106,830 | ||
Accounts receivable
|
950,000 | |||
Other assets
|
112,407 | |||
Leasehold improvements
|
158,819 | |||
Construction-in-process
|
81,017 | |||
Goodwill
|
12,370,000 | |||
Patents and patent related costs
|
10,000,000 | |||
Assumption of liabilities
|
(1,985,073 | ) | ||
Total allocation of purchase price(*)
|
$ | 21,794,000 | ||
The Company plans to amortize the leasehold improvements over their estimated service lives or the remaining terms of the related leases, whichever are shorter. Patents and patent related costs will be amortized over the 15 year remaining life of the patents. | ||
(*) | The purchase price of $21,794,000 is an estimate based on the assumptions listed in the Unaudited Pro Forma Condensed Combined Financial Statements section of this document. Actual results could vary significantly from this estimate. Any adjustments within one year would adjust the purchase price. Adjustments after one year of the acquisition date are remeasured to fair value at each reporting date until the contingency is resolved and the changes in fair value are recognized in earnings in accordance with ASC 805 Business Combinations. | |
(2) | The operations of TerraSphere Systems, LLC are consolidated with the operations of Converted Organics Inc. assuming that the transaction was completed on January 1, 2009. | |
(3) | Amortization expense related to the fair value assigned to the patent and patent related costs. | |
(4) | Earnings per share has been recalculated to reflect the number of common stock shares issued in acquiring TerraSphere. |